Mutant kanamycin nucleotidyltransferases from S. aureus

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

06723543

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to a novel kanamycin nucleotidyltransferase with markedly improved thermostability, a selective marker using the same, and a screening method for thermophilic bacteria such as
Thermus thermophilus
using said selective marker.
BACKGROUND OF THE INVENTION
Thermophilic bacteria have attracted attention due to the applicability of their proteins in biotechnology. Since the proteins are stable at extremes of pH, they crystallize easily in comparison to non-thermophilic proteins, are easy to handle, and are useful as a good research material in the study of interrelation between enzyme structure and its function. However, when thermophilic protein is expressed in
E. coli,
its natural conformation may not be reproduced. These proteins, since standard tools of genetic engineering cannot be employed, cannot be expressed in thermophilic bacteria at high temperatures. This prevents an examination of the biological role of these proteins by knocking out genes with functions that cannot be predicted from the sequence data obtained from the genome project, followed by their reintroduction.
Thermus thermophilus,
which belongs to a Eubacterium, is an attractive organism which can be grown at the highest temperatures (50-82° C.) among organisms whose molecular biology is under study.
The sequence analysis of the entire genome of highly thermophilic
Thermus thermophilus
is currently in progress. Sequence research on the entire genome will soon be completed in Japan (HB8 strain) and Germany (HB27 strain). As with other genome projects, main interest is not in the sequence itself, but has shifted to functional or structural genomics, which is post-sequencing research.
There is a project to organizationally research the structure and biological function of
T. thermophilus
protein. Therefore, there is a need to rapidly develop genetic engineering tools. The most indispensable tool is an easy-to-use selective marker.
Until now, there were only 2 selective systems that could be used with
T. thermophilus.
One system was a method where an auxotrophic host was selected via a plasmid into which the corresponding gene was incorporated. However, the auxotrophic marker is inconvenient for routine use. This is because, preparation of the selection medium is troublesome, and growth of cells on the nutritionally restricted plate, is slow even under the optimal growth temperature.
Another system used a kanamycin nucleotidyltransferase (KNT) gene that could be used only at under 60° C.
T. thermophilus
has sensitivity to general antibiotics, however, the only antibiotic resistant marker that can be used with
T. thermophilus
is a mutant gene of
Staphylococcus aureus
KNT. However, since this mutant KNT cannot be used at over 60° C. as a selective marker, it is far from ideal. At this temperature which is far below optimal growth temperature (70-75° C.), cell growth is extremely slow. Thus, we began work to improve the thermostability of KNT.
BRIEF SUMMARY OF THE INVENTION
Many attempts have been made to improve the thermostability of proteins. Most attempts were designed rationally based on an understanding of the protein folding and structure formation. For example, the introduction of disulfide bonds, re-sequencing of packing of hydrophobic cores and substitution with proline were attempted. To investigate whether it was possible to realize thermostability through amino acid substitution, a comparison was made of the sequences of homologous proteins of thermophilic and non-thermophilic bacteria. In contrast, irrational methods have also been applied in order to increase thermostability of proteins. Most of this research involved the induction of random mutations followed by a single screening in place of directed evolution which comprises repeating cycles of inducing mutation, selecting, and amplifying the selected mutant. Only 2 or 3 cases of research reported successful improvement of thermostability through directed evolution.
The present inventors employing a strategy based on directed evolution toward the upper limit of the growth temperature of
T. thermophilus,
have succeeded in increasing the thermostability of a kanamycin resistant gene product to the upper limit of the growth temperature. The resultant KNT is a convenient selective marker of thermophilic bacteria such as
T. thermophilus.
In other words, the present invention provides the following (1)-(9):
(1) A mutant kanamycin nucleotidyltransferase having one or more point mutations selected from a group consisting of Met57Leu, Ala62Val, Ser94Pro, Ser203Pro, Asp206Val, His207Gln, Ser220Pro, Ile234Val and Thr238Ala as against the protein comprising the amino acid sequence indicated by SEQ ID NO: 1, and having improved thermostability.
(2) A mutant kanamycin nucleotidyltransferase with improved thermostability, wherein it comprises the amino acid sequence indicated by SEQ ID NO: 2.
(3) The kanamycin nucleotidyltransferase according to (1) above, wherein it comprises the amino acid sequence indicated in SEQ ID NO: 3.
(4) A kanamycin nucleotidyltransferase gene encoding the kanamycin nucleotidyltransferase according to any one of (1) to (3) above.
(5) A plasmid comprising the gene according to (4) above.
(6) A transformant comprising the plasmid according to (5) above.
(7) A selective marker for thermophilic bacteria characterized in that it is the gene according to (4) above.
(8) A method for screening thermophilic bacteria wherein the selective marker according to (7) above is used.
(9) The screening method according to (8) above, wherein said thermophilic bacteria is
Thermus thermophilus.
In the present invention, the mutant strain with the greatest thermostability has 19 amino acid substitutions when compared with the form prior to mutation. Thermostability was increase by 20° C., however, no great change in enzyme activity per se was observed. Most of the altered residues reside on the surface of the protein molecule. Interestingly, 5 substitutions out of 19 were substitutions of the existing residue by proline. The evolved kanamycin-resistant gene product is capable of becoming a selective marker at the optimum growth temperature of
T. thermophilus.
The development of such convenient genetic engineering tools will promote the post-sequencing research of
T. thermophilus.


REFERENCES:
Matsumura et al. Single amino acid replacements affecting the thermostability of kanamycin nucleotidyltransferase. Molecular General Genetics (MGG) 1986 204:355-358.*
Jun Hoseki, et al. “Directed Evolution of Thermostable Kanamycin-Resistance Gene: A Convenient Selection Marker forThermus thermophilus” J. Biochem. 126(5):951-956 (1999).
Masazumi Matsumura et al. “Screening for Thermostable Mutant of Kanamycin Nucleotidyltransferase by the Use of a Transformation System for a Thermophile,Bacillus stearothermophilus” J. Biol. Chem. 260(28):15298-15303 (1985).
Hans H. Liao “Thermostable Mutants of Kanamycin Nucleotidyltransferase are also More Stable to Proteinase K, Urea, Detergents, and Water-Miscible Organic Solvents”Enzyme Microb. Technol. 15(4):286-292 (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mutant kanamycin nucleotidyltransferases from S. aureus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutant kanamycin nucleotidyltransferases from S. aureus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant kanamycin nucleotidyltransferases from S. aureus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3219476

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.